Adam Feire is Global Head Search & Evaluation within Novartis Corporate & Business Development where he leads a global team focused on identification and evaluation of partnering opportunities from discovery through commercial stage across all therapeutic areas and technology spaces.
Previously, Adam was Executive Director, Novartis Institutes for BioMedical Research (NIBR) BD&L, and instrumental in establishing a portfolio of Ophthalmology gene therapies through partnerships and asset acquisitions. He has more than 15 years of experience in the pharmaceutical industry, leading drug discovery project teams and drug candidates into the clinic, establishing technology licensing deals and collaborative partnerships, and leading early and late phase search and evaluation efforts. Adam holds a B.S. degree in Biology from James Madison University and a PhD in Cellular and Molecular Biology from the University of Wisconsin, Madison.
Previously, Adam was Executive Director, Novartis Institutes for BioMedical Research (NIBR) BD&L, and instrumental in establishing a portfolio of Ophthalmology gene therapies through partnerships and asset acquisitions. He has more than 15 years of experience in the pharmaceutical industry, leading drug discovery project teams and drug candidates into the clinic, establishing technology licensing deals and collaborative partnerships, and leading early and late phase search and evaluation efforts. Adam holds a B.S. degree in Biology from James Madison University and a PhD in Cellular and Molecular Biology from the University of Wisconsin, Madison.
Speaking In
2:15 PM - 2:30 PM
Tuesday, June 6
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
